Sotera Health (NASDAQ:SHC) Issues FY 2026 Earnings Guidance

Sotera Health (NASDAQ:SHC) updated its FY 2026 earnings guidance on Tuesday. The company provided earnings per share guidance of 0.930-1.01 for the period, compared to the consensus earnings per share estimate of 0.910. The company issued revenue guidance of $1.2 billion-$1.3 billion, compared to the consensus revenue estimate of $1.2 billion.

Sotera Health Price Performance

Shares of NASDAQ:SHC opened at $17.49 on Tuesday. The firm has a fifty day moving average price of $17.99 and a two-hundred day moving average price of $16.81. The company has a market cap of $4.97 billion, a price-to-earnings ratio of 92.06 and a beta of 1.82. The company has a debt-to-equity ratio of 4.04, a current ratio of 2.38 and a quick ratio of 2.18. Sotera Health has a one year low of $9.53 and a one year high of $19.85.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the company. Zacks Research lowered Sotera Health from a “strong-buy” rating to a “hold” rating in a research note on Friday, January 30th. BMO Capital Markets initiated coverage on shares of Sotera Health in a research note on Thursday, November 13th. They issued an “outperform” rating and a $19.00 target price on the stock. William Blair assumed coverage on shares of Sotera Health in a research report on Thursday, December 18th. They set an “outperform” rating for the company. Wells Fargo & Company cut shares of Sotera Health to an “overweight” rating in a research note on Thursday, January 8th. Finally, JPMorgan Chase & Co. raised their price objective on shares of Sotera Health from $14.00 to $16.00 and gave the company a “neutral” rating in a research report on Wednesday, November 5th. Seven equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $20.00.

Insider Buying and Selling

In other Sotera Health news, CEO Michael B. Jr. Petras sold 434,104 shares of the business’s stock in a transaction on Monday, December 8th. The shares were sold at an average price of $16.45, for a total value of $7,141,010.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Pincus & Co. Warburg sold 9,720,000 shares of the company’s stock in a transaction dated Wednesday, December 3rd. The shares were sold at an average price of $16.33, for a total transaction of $158,727,600.00. Following the sale, the director owned 34,102,952 shares of the company’s stock, valued at approximately $556,901,206.16. The trade was a 22.18% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 17,384,104 shares of company stock worth $284,024,511 in the last 90 days. 55.12% of the stock is owned by company insiders.

Hedge Funds Weigh In On Sotera Health

A number of large investors have recently bought and sold shares of the stock. Sculptor Capital LP boosted its stake in shares of Sotera Health by 27.2% during the second quarter. Sculptor Capital LP now owns 11,500,000 shares of the company’s stock valued at $127,880,000 after purchasing an additional 2,462,489 shares during the period. Janus Henderson Group PLC raised its holdings in Sotera Health by 4.8% during the 4th quarter. Janus Henderson Group PLC now owns 6,772,059 shares of the company’s stock valued at $119,460,000 after buying an additional 312,191 shares during the last quarter. State Street Corp boosted its position in Sotera Health by 21.0% during the 4th quarter. State Street Corp now owns 5,965,326 shares of the company’s stock valued at $105,228,000 after buying an additional 1,035,457 shares during the period. Dimensional Fund Advisors LP grew its holdings in Sotera Health by 11.3% in the 4th quarter. Dimensional Fund Advisors LP now owns 5,160,594 shares of the company’s stock worth $91,036,000 after acquiring an additional 524,012 shares during the last quarter. Finally, AQR Capital Management LLC grew its holdings in Sotera Health by 1,206.2% in the 4th quarter. AQR Capital Management LLC now owns 2,864,106 shares of the company’s stock worth $50,523,000 after acquiring an additional 2,644,831 shares during the last quarter. 91.03% of the stock is owned by hedge funds and other institutional investors.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.